Mymobility Knee ROM

Launched by ZIMMER BIOMET · Mar 6, 2025

Keywords

ClinConnect Summary

The Mymobility Knee ROM clinical trial is studying how well a new device, called mymobility, measures the movement of the knee compared to traditional methods used by doctors. This study aims to see if the measurements taken by the device match those taken by a clinician using a special tool called a goniometer, which helps assess how far the knee can bend or straighten.

To be eligible for this trial, participants must be at least 18 years old and willing to sign a consent form agreeing to take part in the study. However, people who are currently in another study that could affect the results, those with certain complex knee problems, or individuals who are pregnant or considered vulnerable (like prisoners or those with mental health issues) cannot participate. The trial is currently not recruiting participants yet, but once it starts, those who join can expect to help researchers learn more about knee movement and potentially improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient is a minimum of 18 years of age
• • Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent form
• Exclusion Criteria:
• • The patient is currently participating in any other study that would hinder the assessor's ability to measure knee ROM
• • Complex primary knee pathology with significant restrictions on the range of motion per surgeon discretion
• • Patient is pregnant or considered a member of a protected population (e.g. prisoner, mentally incompetent, etc.)